Oramed Pharmaceuticals Inc stock is traded at $3.86, with a volume of 112,540. It is down -0.77% in the last 24 hours and down -11.87% over the past month. Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
Previous Close:
$3.89
Open:
$3.90
24h Volume:
112,540
Relative Volume:
1.04
Market Cap:
$160.57M
Revenue:
$2.00M
Net Income/Loss:
$109.16M
P/E Ratio:
1.49
EPS:
$2.58
Net Cash Flow:
-$9.11M
1W Performance:
-6.08%
1M Performance:
-11.87%
6M Performance:
-1.53%
1Y Performance:
+75.45%
1-Day Range:
$3.84$4.00
1-Week Range:
$3.84$4.14
52-Week Range:
$2.09$5.47
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
Name
Oramed Pharmaceuticals IncSector
HealthcareIndustry
BiotechnologyPhone
646-844-1164Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS